tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

PSTV Stock Latest News

Plus Therapeutics presents data at 2024 CNS Annual Meeting
The FlyPlus Therapeutics presents data at 2024 CNS Annual Meeting
2d ago
PSTV
Plus Therapeutics Showcases New Interim ReSPECT-GBM Phase 2 Trial Data at the 2024 Congress of Neurological Surgeons Annual Meeting
PremiumPress Releases
Plus Therapeutics Showcases New Interim ReSPECT-GBM Phase 2 Trial Data at the 2024 Congress of Neurological Surgeons Annual Meeting
2d ago
PSTV
Plus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
PremiumPress Releases
Plus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
16d ago
PSTV
Plus Therapeutics reports Q2 EPS (71c), consensus (53c)
PremiumThe Fly
Plus Therapeutics reports Q2 EPS (71c), consensus (53c)
1M ago
PSTV
Plus Therapeutics presents FORESEE trial results
PremiumThe Fly
Plus Therapeutics presents FORESEE trial results
1M ago
PSTV
Plus Therapeutics Presents Positive Clinical Trial Results at the 2024 SNO/ASCO CNS Metastases Conference
PremiumPress ReleasesPlus Therapeutics Presents Positive Clinical Trial Results at the 2024 SNO/ASCO CNS Metastases Conference
1M ago
PSTV
Plus Therapeutics Presents Positive Interim ReSPECT-LM Phase 1 Data for Leptomeningeal Metastases at 2024 SNO/ASCO CNS Metastases Conference
Premium
Press Releases
Plus Therapeutics Presents Positive Interim ReSPECT-LM Phase 1 Data for Leptomeningeal Metastases at 2024 SNO/ASCO CNS Metastases Conference
1M ago
PSTV
Plus Therapeutics presents interim ReSPECT-LM phase 1 data
Premium
The Fly
Plus Therapeutics presents interim ReSPECT-LM phase 1 data
1M ago
PSTV
Is PSTV a Buy, Before Earnings?
PremiumPre-Earnings
Is PSTV a Buy, Before Earnings?
1M ago
PSTV
Plus Therapeutics to Announce Second Quarter Financial Results and Host Conference Call on August 14, 2024
PremiumPress Releases
Plus Therapeutics to Announce Second Quarter Financial Results and Host Conference Call on August 14, 2024
1M ago
PSTV
Plus Therapeutics Showcases Leptomeningeal Metastases Programs at 2024 SNO/ASCO Conference
PremiumPress Releases
Plus Therapeutics Showcases Leptomeningeal Metastases Programs at 2024 SNO/ASCO Conference
2M ago
PSTV
Plus Therapeutics to Present at the Gordon Research Conference Radionuclide Theranostics for the Management of Cancer
PremiumPress Releases
Plus Therapeutics to Present at the Gordon Research Conference Radionuclide Theranostics for the Management of Cancer
3M ago
PSTV
Plus Therapeutics CMO Dr. LaFrance Resignation Announced
PremiumCompany AnnouncementsPlus Therapeutics CMO Dr. LaFrance Resignation Announced
3M ago
8K
PSTV
Plus Therapeutics files to sell 10.77M shares of common stock for holders
Premium
The Fly
Plus Therapeutics files to sell 10.77M shares of common stock for holders
3M ago
PSTV
Plus Therapeutics Expands Management Team and Reports $3.3M Advance Payment from CPRIT
Premium
Press Releases
Plus Therapeutics Expands Management Team and Reports $3.3M Advance Payment from CPRIT
4M ago
PSTV
Plus Therapeutics appoints Fuller as VP, reports $3.3M advance payment
PremiumThe Fly
Plus Therapeutics appoints Fuller as VP, reports $3.3M advance payment
4M ago
PSTV
Y-mAbs Therapeutics appoints LaFrance as Chief Development Officer
PremiumThe Fly
Y-mAbs Therapeutics appoints LaFrance as Chief Development Officer
4M ago
PSTV
YMAB
Plus Therapeutics Secures Loan to Terminate Debt and Regain Freedom
PremiumCompany Announcements
Plus Therapeutics Secures Loan to Terminate Debt and Regain Freedom
4M ago
8K
PSTV
Plus Therapeutics Announces New Employment Inducement Grants
PremiumPress Releases
Plus Therapeutics Announces New Employment Inducement Grants
4M ago
PSTV
Plus Therapeutics at Risk of Nasdaq Delisting: A Dive into Compliance Challenges and Potential Market Impact
PremiumCompany AnnouncementsPlus Therapeutics at Risk of Nasdaq Delisting: A Dive into Compliance Challenges and Potential Market Impact
4M ago
PSTV
Plus Therapeutics reports Q1 EPS (75c), consensus ($1.09)
Premium
The Fly
Plus Therapeutics reports Q1 EPS (75c), consensus ($1.09)
4M ago
PSTV
Plus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024
Premium
Press Releases
Plus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024
4M ago
PSTV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >